High incidence of repeat anginal attacks despite treatment with calcium-channel blockers in patients with coronary spastic Angina

Circulation Journal

Volumn 73, Issue 3, 2009, Pages 512-515

  Ogawa, Takayuki ^a   Komukai, Kimiaki ^a   Ogawa, Kazuo ^a   Kosuga, Tsuneharu ^a   Nagoshi, Tomohisa ^a   Minai, Kosuke ^a   Sakamoto, Hiroshi ^a   Hashimoto, Koichi ^a   Yoshida, Satoru ^a   Taniguchi, Ikuo ^a   Mochizuki, Seibu ^b   Yoshimura, Michihiro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MUSASHINO UNIVERSITY   (Japan)

Author keywords

Anginal attacks; Calcium channel blockers; Coronary spasm

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; MANIDIPINE; NICORANDIL; NIFEDIPINE; NISOLDIPINE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BACKACHE; BEDTIME DOSAGE; COLD SWEAT; CORONARY ARTERY SPASM; CORONARY RISK; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; DRUG WITHDRAWAL; DYSLIPIDEMIA; EVENING DOSAGE; FEMALE; FOLLOW UP; GINGIVA HYPERPLASIA; HEART DEATH; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; HYPERTENSION; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; RASH; SMOKING; SORE THROAT; STATISTICAL ANALYSIS; SYMPTOM; THIRST; THORAX PAIN;

ACETYLCHOLINE; AGED; ANGINA PECTORIS, VARIANT; CALCIUM CHANNEL BLOCKERS; CORONARY VASOSPASM; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NICORANDIL; NITRATES; PROGNOSIS; QUALITY OF LIFE; RECURRENCE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 62649106173     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0501     Document Type: Article

References (18)

1. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction: The case for a distinction. Circulation 1990; 81: 1983-1991.
2. Kim PJ, Seung KB, Kim DB, Her SH, Shin DI, Jang SW, et al. Clinical and angiographic characteristics of acute myocardial infarction caused by vasospastic angina without organic coronary heart disease. Circ J 2007; 71: 1383-1386.
3. Antman E, Muller J, Goldberg S, MacAlpin R, Rubenfre M, Tabatznik B, et al. Nifedipine therapy for coronary-artery spasm: Experience in 127 patients. N Engl J Med 1980; 302: 1269-1273.
4. Kimura E, Kishida H. Treatment of variant angina with drugs: A survey of 11 cardiology institutes in Japan. Circulation 1981; 63: 844-848.
5. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-term prognosis for patients with variant angina and infuential factors. Circulation 1988; 78: 1-9.
6. Nishijima T, Nakayama M, Yoshimura M, Abe K, Yamamuro M, Suzuki S, et al. The endothelial nitric oxide synthase gene -786T/C polymorphism is a predictive factor for reattacks of coronary spasm. Pharmacogenet Genomics 2007; 17: 581-587.
7. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, et al. Nitric oxide activity is defcient in spasm arteries of patients with coronary spastic angina. Circulation 1996; 94: 266-271.
8. Yasue H, Kugiyama K. Coronary spasm: Clinical features and pathogenesis. Intern Med 1997; 36: 760-765.
9. Maseri A, Louis F. Role of coronary artery spasm in symptomatic and silent myocardial ischemia [Bishop lecture]. J Am Coll Cardiol 1987; 9: 249-262.
10. Takaoka K, Yoshimura M, Ogawa H, Kugiyama K, Nakayama M, Shimasaki Y, et al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: Role of cigarette smoking. Int J Cardiol 2000; 72: 121-126.
11. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998; 103: 65-69.
12. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T-786->C mutation in the 5′-fanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-2870.
13. Itoh T, Mizuno Y, Harada E, Yoshimura M, Ogawa H, Yasue H. Coronary spasm is associated with chronic low-grade infammation. Circ J 2007; 71: 1074-1078.
14. Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 2002; 40: 567-572.
15. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Effcacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.
16. Ray KK, Cannon CP. The potential relevance of the multiple lipidindependent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol 2005; 46: 1425-1433.
17. Waters DD. What the statin trials have taught us. Am J Cardiol 2006; 98: 129-134.
18. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, et al; SCAST (Statin and Coronary Artery Spasm Trial) Investigators. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fuvastatin, on coronary spasm after withdrawal of calciumchannel blockers. J Am Coll Cardiol 2008; 51: 1742-1748.